SOLVENTUM CORPORATION Stock-Based Compensation
SOLVENTUM CORPORATION (SOLV) reported Stock-Based Compensation of $89.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-05
- SOLVENTUM CORPORATION share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $38.00M, a 11.76% increase year-over-year.
- SOLVENTUM CORPORATION share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $51.00M, a 4.08% increase year-over-year.
- SOLVENTUM CORPORATION share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $37.00M, a 48.00% increase year-over-year.
- SOLVENTUM CORPORATION share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $41.00M, a 51.85% increase year-over-year.
- SOLVENTUM CORPORATION share-based payment arrangement, noncash expense for fiscal 2025 was $161.00M, a 43.75% increase from fiscal 2024.
- SOLVENTUM CORPORATION share-based payment arrangement, noncash expense for fiscal 2024 was $112.00M, a 187.18% increase from fiscal 2023.
- SOLVENTUM CORPORATION share-based payment arrangement, noncash expense for fiscal 2023 was $39.00M, a 5.41% increase from fiscal 2022.
- SOLVENTUM CORPORATION share-based payment arrangement, noncash expense for fiscal 2022 was $37.00M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $38.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $89.00M 10-Q · filed 2026-08-05 | $126.00M derived: sum of 3 quarters · filed 2026-08-05 | $167.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $51.00M 10-Q · filed 2026-05-05 | $88.00M derived: sum of 2 quarters · filed 2026-05-05 | $129.00M derived: sum of 3 quarters · filed 2026-05-05 | $163.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $37.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $78.00M derived: sum of 2 quarters · filed 2026-02-27 | $112.00M derived: sum of 3 quarters · filed 2026-08-05 | $161.00M 10-K · filed 2026-02-27 |
| 2025-09-30 | $41.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $75.00M derived: sum of 2 quarters · filed 2026-08-05 | $124.00M 10-Q · filed 2025-11-06 | $149.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $34.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $83.00M 10-Q · filed 2026-08-05 | $108.00M derived: sum of 3 quarters · filed 2026-08-05 | $135.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $49.00M 10-Q · filed 2026-05-05 | $74.00M derived: sum of 2 quarters · filed 2026-05-05 | $101.00M derived: sum of 3 quarters · filed 2026-05-05 | $157.00M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $25.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $52.00M derived: sum of 2 quarters · filed 2026-02-27 | $108.00M derived: sum of 3 quarters · filed 2026-02-27 | $112.00M 10-K · filed 2026-02-27 |
| 2024-09-30 | $27.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $83.00M derived: sum of 2 quarters · filed 2025-11-06 | $87.00M 10-Q · filed 2025-11-06 | $94.00M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $56.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $60.00M 10-Q · filed 2025-08-08 | $67.00M derived: sum of 3 quarters · filed 2026-02-27 | $73.00M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $4.00M 10-Q · filed 2025-05-09 | $11.00M derived: sum of 2 quarters · filed 2026-02-27 | $17.00M derived: sum of 3 quarters · filed 2026-02-27 | $25.00M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $13.00M derived: sum of 2 quarters · filed 2026-02-27 | $21.00M derived: sum of 3 quarters · filed 2026-02-27 | $39.00M 10-K · filed 2026-02-27 |
| 2023-09-30 | $6.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $14.00M derived: sum of 2 quarters · filed 2024-11-08 | $32.00M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $8.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $26.00M 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | $18.00M 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | $37.00M 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |